Finalized clinical trials

Since 2001 many clinical trials have been performed using TrichoScan® as an analytical tool to measure hair densities. Some of these studies have been published: 

Blume-Peytavi U, Issiakhem Z, Gautier S, Kottner J, Wigger-Alberti W, Fischer T, Hoffmann R, Tonner F, Bouroubi A, Voisard JJ
Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
J Cosmet Dermatol. 2018 Apr 16. doi: 10.1111/jocd.12541. Link

J Gassmueller, R Hoffmann and A Webster
Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
British Journal of Dermatology (2008) 158, 109–115

R Hoffmann
A 4-month, open-label study evaluating the efficacy of eflornithine 11.5% cream in the treatment of unwanted facial hair in women using TrichoScan.
Eur J Dermatol (2008) 18 (1): 65-70 Download

U Blume-Peytavi, C Kunte, A Krisp, N Garcia Bartels, U Ellwanger, R Hoffmann
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
JDDG (2007) 5 (5): 391-395 Download

R Hoffmann
An open-label trial evaluating the efficacy of erflornithine 11,5% cream in the treatment of unwanted facial hair (UFH) in women using the TrichoScan.
Poster presented at the 16th Congress of the European Academy of Dermatology and Venereology (EADV), Vienna (2007)

J Gassmueller, R Hoffmann and A Webster
Treatment of androgenetic alopecia using topical fulvestrant solution in males and post menopausal females.
Poster presented at the European Hair Research Society Annual Meeting, London, UK (2006)